Feedback / Questions
ACTM-838 - Actym Therap
https://www.prnewswire.com/news-releases/actym-therapeutics-announces-ind-clearance-for-phase-1-clinical-trial-investigating-lead-program-actm-838-in-patients-with-solid-tumors-302159288.html
May 30, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next